companydata.dkcompanydata.dk

Synamics Therapeutics ApS: Financial statements 2024

CVR: 44258048

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Synamics Therapeutics ApS (CVR 44258048) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,694,760 and a net result of DKK -1,554,274. Equity in the 2024 report amounted to DKK 472,772. The solvency ratio was 13.3%.

Gross Profit
DKK -1,694,760
Profit/Loss
DKK -1,554,274
Equity
DKK 472,772
Total Assets
DKK 3,549,533

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Per Falholt joins the board of Synamics Therapeutics ApSJul 9, 2024

As of July 9, 2024, Per Falholt has joined the board of directors of Synamics Therapeutics ApS.

Helder Takashi Imoto Nakaya leaves the board of Synamics Therapeutics ApSJul 9, 2024

As of July 9, 2024, Helder Takashi Imoto Nakaya has left the board of directors of Synamics Therapeutics ApS.

Synamics Therapeutics ApS publishes interim reportMay 24, 2024

Synamics Therapeutics ApS has published its interim report for the period August 24, 2023 to December 31, 2023.

About Synamics Therapeutics ApS

Synamics Therapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Violet Zahedi. The board consists of Aaron Daniel Capar (chair), Albert Jelke Kooistra, Per Falholt and Violet Zahedi. The company is owned by Synamics Therapeutics Inc.. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 129,466 and a net result of DKK -588,453 compared with DKK -1,554,274 the year before. Equity in the 2025 report amounted to DKK -114,946.

Source: annual report 2025, Danish Business Authority

Other financial years